Health Care: Drugs

InterMune Inc (ITMN: NASDAQ)

$46.4 n/a | n/a%
07/23/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 46.40
52 Week High 47.72
52 Week Low 10.95
Avg. Daily Vol. (Mil) 2.22
Beta (3 year) 3.63
Share Related Items
Mkt Cap (Mil) 4,588.18
Shares Out (Mil) 98.88
Float (Mil) 67.79
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 7.20
Current Ratio 7.60
LT Debt/ Equity 2.77
Total Debt / Equity 2.77
Valuation Ratios
Price Earnings n.a.
Price/Sales 86.78
Price/Book 48.26
Price/Cash Flow -21.50
Per Share Data
Earnings -2.94
Sales 0.53
Book Value 0.96
Cash Flow -2.16
Business Summary
InterMune, Inc., is a biotechnology company. It is engaged in the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases.
General Information
3280 Bayshore Boulevrad
Brisbane, CA 94005
www.intermune.com
Industry : Drugs
Sector: Health Care
Employees: 335
CEO: Daniel G. Welch
Short Interest
Current Month (Mil) 10.50
Previous Month (Mil) 11.33
Short Interest Ratio (Days) 5.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -54.20
Return on Investments -61.70
Profitability
Gross Margin 96.40
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ITMN

Latest ITMN Headlines from TheStreet

More Financial News for ITMN

Press Releases for ITMN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter